News Quantified

HBIO – harvard bioscience, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Wall Street

Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Wall Street

Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report [Yahoo! Finance]

11.1%

BEAT

Speculative Buy

Speculative Buy

Speculative Buy

Speculative Buy

Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30

Form 8-K HARVARD BIOSCIENCE INC For: Nov 06

Form SCHEDULE 13G/A HARVARD BIOSCIENCE INC Filed by: Leviticus Partners LP

Form 4 HARVARD BIOSCIENCE INC For: Sep 05 Filed by: DENELSKY STEPHEN J

Form 3 HARVARD BIOSCIENCE INC For: Sep 05 Filed by: DENELSKY STEPHEN J

Top News Gainers

7/25 Form 8-K HARVARD BIOSCIENCE INC For: Jul 25 45.9%

3/23 Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19 14.0%

2/26 Form 8-K HARVARD BIOSCIENCE INC For: Feb 26 13.8%

2/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.50 to $4.00. They now have a "speculative buy" rating on the stock. 13.1%

11/13 Form 4 HARVARD BIOSCIENCE INC For: Nov 11 Filed by: Green James W 12.2%

9/9 Harvard Bioscience Announces Strategic Action Plan and Financial Targets 10.4%

8/20 Form 4 HARVARD BIOSCIENCE INC For: Aug 20 Filed by: Loewald Thomas W 10.4%

7/18 Harvard Bioscience Names Michael Rossi Chief Financial Officer 9.6%

12/23 Form 8-K HARVARD BIOSCIENCE INC For: Dec 17 6.6%

4/8 Form 3 HARVARD BIOSCIENCE INC For: Apr 06 Filed by: Steele Susan M. 6.4%

Top News Decliners

7/8 Form 8-K HARVARD BIOSCIENCE INC For: Jul 02 -16.3%

5/8 Form 8-K HARVARD BIOSCIENCE INC For: May 08 -10.9%

7/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. -10.1%

11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus 0.030 ActVsEst 0.010 - Beat -8.5%

8/1 Form 4 HARVARD BIOSCIENCE INC For: Aug 01 Filed by: Eade Katherine A. -8.2%

3/16 Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 -7.7%

4/23 Harvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET -7.3%

11/8 Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 -5.8%

7/3 Form SC 13G/A HARVARD BIOSCIENCE INC Filed by: First Light Asset Management, LLC -5.0%

3/3 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock. -4.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day